It is, therefore, encouraging that recent reports of a newly developed assay analyzing a CNS-specific tau isomer, brain-derived tau, have shown promising results, indicating that protein as an emerging biomarker in acute stroke management [38, 39]. The gene discussed is MAPT; the disease is Stroke.